|
Parameters
|
Male
|
Female
|
|---|
|
Control*
|
Treated*
|
Control*
|
Treated*
|
|---|
|
Urea (Mmol/L)
|
42.633 ± 0.839
|
42.45 ± 0.476
|
40.13 ± 0.991
|
37.933 ± 0.987
|
|
Creatinine (µmol/L)
|
0.774 ± 0.026
|
0.770 ± 0.009
|
0.618 ± 0.024
|
0.566 ± 0.008
|
|
Total bilirubin (µmol/L)
|
2.376 ± 0.093
|
2.348 ± 0.014
|
1.76 ± 0.025
|
1.695 ± 0.015
|
|
Aspartate aminotransferase (AST) (U/L)
|
208.96 ± 4.192
|
212.13 ± 0.705
|
160.66 ± 2.708
|
162.08 ± 0.351
|
|
Alanine aminotransferase (ALT) (U/L)
|
79.95 ± 2.095
|
77.80 ± 0.566
|
61.33 ± 2.677
|
64.186 ± 0.520
|
|
Alkaline phosphatase (ALP) (U/L)
|
258.3 ± 2.510
|
260.3 ± 0.813
|
183.33 ± 1.612
|
185.13 ± 0.305
|
- * Values are expressed as mean ± SEM (n = 6 for each group). There was no significant difference (p > 0.05) between the test and control groups as indicated by Post hoc Tukey’s t-test
